We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $22.2B
1-Year Est. Return 58.34%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$103M
Cap. Flow %
1.58%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 36.21%
2 Technology 15.85%
3 Financials 11.81%
4 Consumer Discretionary 8.38%
5 Communication Services 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
1
Amgen
AMGN
$236B
$190M 2.92%
976,575
-98,475
-9% -$19.2M
BIIB icon
2
Biogen
BIIB
$32.6B
$171M 2.63%
569,741
+61,805
+12% +$19.7M
MSFT icon
3
Microsoft
MSFT
$3.71T
$160M 2.46%
1,575,263
+160,008
+11% +$17.1M
CELG
4
DELISTED
Celgene Corp
CELG
$135M 2.08%
2,111,324
+825,120
+64% +$60.9M
REGN icon
5
Regeneron Pharmaceuticals
REGN
$85.2B
$130M 2.01%
349,354
+2,971
+0.9% +$1.09M
AMZN icon
6
Amazon
AMZN
$2.79T
$128M 1.96%
1,698,560
+172,100
+11% +$14.3M
AAPL icon
7
Apple
AAPL
$4.67T
$113M 1.74%
2,874,624
+298,988
+12% +$14.5M
VRTX icon
8
Vertex Pharmaceuticals
VRTX
$138B
$105M 1.62%
635,385
+177,234
+39% +$30.7M
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.14T
$101M 1.56%
1,938,980
-129,280
-6% -$6.99M
GILD icon
10
Gilead Sciences
GILD
$187B
$98.4M 1.51%
1,573,913
+234,620
+18% +$16.4M
BABA icon
11
Alibaba
BABA
$281B
$78.7M 1.21%
574,395
+17,023
+3% +$2.52M
MRK icon
12
Merck
MRK
$371B
$76.4M 1.17%
1,048,060
-253,420
-19% -$17.9M
PG icon
13
Procter & Gamble
PG
$340B
$71.6M 1.1%
778,671
-112,192
-13% -$10M
BMY icon
14
Bristol-Myers Squibb
BMY
$136B
$70.8M 1.09%
1,362,502
+335,865
+33% +$18M
ILMN icon
15
Illumina
ILMN
$33B
$69.3M 1.07%
237,581
+47,447
+25% +$14.7M
V icon
16
Visa
V
$700B
$63.2M 0.97%
478,888
-7,853
-2% -$1.08M
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
$60.9M 0.94%
625,897
+145,077
+30% +$17.1M
META icon
18
Meta Platforms (Facebook)
META
$1.57T
$60.6M 0.93%
462,324
-58,274
-11% -$8.44M
DIS icon
19
Walt Disney
DIS
$182B
$57.1M 0.88%
521,145
-35,504
-6% -$4.04M
UNH icon
20
UnitedHealth
UNH
$356B
$52.9M 0.81%
212,298
+66,712
+46% +$17.6M
HD icon
21
Home Depot
HD
$320B
$51.9M 0.8%
301,897
+19,677
+7% +$3.53M
ABBV icon
22
AbbVie
ABBV
$453B
$50.5M 0.78%
547,354
+26,953
+5% +$2.37M
JPM icon
23
JPMorgan Chase
JPM
$953B
$49.9M 0.77%
510,696
-29,237
-5% -$3.12M
JNJ icon
24
Johnson & Johnson
JNJ
$663B
$48.7M 0.75%
377,524
-47,205
-11% -$6.58M
XOM icon
25
ExxonMobil
XOM
$656B
$46.6M 0.72%
683,472
-250,004
-27% -$19.6M
1
2 3 4 5

Similar funds

DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $22.1B AUM 41.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $22.1B AUM 45.54% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $22.3B AUM 36.19% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $22.5B AUM 50.37% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.